Cardiff Oncology Inc. welcomed Mani Mohindru as interim CEO and simultaneously provided what the company dubbed a “positive” ...

Colorectal cancer (CRC) became the leading cause of cancer -related deaths in 2023 among patients aged younger than 50 in the ...

Most of you probably don’t know that I serve on the City of Farmington’s Community Relations Commission, commonly known as ...

Shield’s FDA-approved blood test drives cancer screening growth, pricing power, and cash-flow upside. Click for this GH ...

CRC Etch-10 delivers exceptional adhesion and corrosion resistance – ensuring equipment stays primed for the long haul.

The latest results from the phase 1b/2 OrigAMI-1 study showed an overall response rate (ORR) of 51% and a median progression-free survival (PFS) of 9.2 months. The data were especially encouraging in ...

In an interview with Targeted Oncology, Filippo Pietrantonio, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, discusses the clinical necessity of overcoming resistance to first-generation EGFR ...

New research shows that gut bacteria and metabolites may reveal early warning signs of multiple gastrointestinal diseases. Scientists have uncovered biological signals in the gut that may make it ...

One of the major promises of President John Dramani Mahama in the run-up to the 2024 general election was to scrap the ...

Increased stiffness of the colon, spurred by chronic inflammation, may encourage the development and progression of ...

Researchers investigated whether the time interval between a positive FIT result and follow-up colonoscopy is linked to risk for CRC.

I never imagined colorectal cancer would become part of my life story. And I certainly never expected it to shape the work I ...